Benzydamine for the prevention of pharyngo-laryngeal pathology following tracheal intubation

Int J Tissue React. 1987;9(2):121-9.

Abstract

A clinical study was carried out to assess the antiinflammatory effectiveness and related properties of this drug. It was performed double-blind in 40 adult patients (ASA I, and II) undergoing major otorhinolaryngological surgical procedures with tracheal intubation. The patients received benzydamine at random (n = 20), or a similar solution without the active substance (n = 20). The following parameters were considered: physical examination, sensations referred from patient, cytologic examination, glottographic examination, and spectrographic examination. The results suggest that benzydamine applied locally at a concentration of 0.3% has therapeutic efficacy without local or systemic side-effects.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial

MeSH terms

  • Administration, Topical
  • Adolescent
  • Adult
  • Benzydamine / therapeutic use*
  • Deglutition Disorders / etiology
  • Deglutition Disorders / prevention & control*
  • Double-Blind Method
  • Female
  • Humans
  • Intubation, Intratracheal / adverse effects*
  • Male
  • Middle Aged
  • Pharyngitis / etiology
  • Pharyngitis / prevention & control*
  • Premedication
  • Pyrazoles / therapeutic use*
  • Random Allocation

Substances

  • Pyrazoles
  • Benzydamine